Table 4.
Studied AR and respective analytical parameters of method validation by fortification of respective matrix, n = 6
| Substance | Bream liver | SPM | ||||
|---|---|---|---|---|---|---|
| LOQ level [μg kg−1] | Recovery [%] | RSD [%] | LOQ level [μg kg−1] | Recovery [%] | RSD [%] | |
| Flocoumafen | 0.2 | 100 | 5.4 | 1.0 | 98 | 6.9 |
| Bromadiolone | 2.0 | 95 | 8.1 | 1.0 | 96 | 4.8 |
| Brodifacoum | 1.0 | 93 | 6.6 | 2.0 | 98 | 5.9 |
| Difenacoum | 0.2 | 96 | 9.7 | 1.0 | 98 | 10.3 |
| Warfarin | 0.2 | 103 | 6.9 | 0.2 | 102 | 7.5 |
| Chlorophacinone | 1.0 | 93 | 7.2 | 2.0 | 116 | 26.3 |
| Coumatetralyl | 0.2 | 110 | 4.1 | 0.2 | 106 | 5.4 |
| Difethialone | 1.0 | 95 | 3.3 | 1.4 | 103 | 4.6 |